Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Delta 9 Cannabis (DN) Competitors

C$0.02
-0.01 (-20.00%)
(As of 05/17/2024 11:23 AM ET)

DN vs. CTX, VPH, WLLW, TMD, and AEZS

Should you be buying Delta 9 Cannabis stock or one of its competitors? The main competitors of Delta 9 Cannabis include Crescita Therapeutics (CTX), Valeo Pharma (VPH), Willow Biosciences (WLLW), Titan Medical (TMD), and Aeterna Zentaris (AEZS). These companies are all part of the "medical" sector.

Delta 9 Cannabis vs.

Crescita Therapeutics (TSE:CTX) and Delta 9 Cannabis (TSE:DN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Crescita Therapeutics has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Delta 9 Cannabis has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crescita Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Delta 9 Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Crescita Therapeutics has a net margin of -11.33% compared to Crescita Therapeutics' net margin of -24.65%. Delta 9 Cannabis' return on equity of -9.95% beat Crescita Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Crescita Therapeutics-11.33% -9.95% -4.61%
Delta 9 Cannabis -24.65%-29,673.63%-10.31%

Crescita Therapeutics received 51 more outperform votes than Delta 9 Cannabis when rated by MarketBeat users. However, 100.00% of users gave Delta 9 Cannabis an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.

CompanyUnderperformOutperform
Crescita TherapeuticsOutperform Votes
60
67.42%
Underperform Votes
29
32.58%
Delta 9 CannabisOutperform Votes
9
100.00%
Underperform Votes
No Votes

Crescita Therapeutics has higher earnings, but lower revenue than Delta 9 Cannabis. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescita TherapeuticsC$17.52M0.53-C$1.99M-C$0.10-4.75
Delta 9 CannabisC$71.07M0.07-C$17.52M-C$0.10-0.20

In the previous week, Delta 9 Cannabis had 1 more articles in the media than Crescita Therapeutics. MarketBeat recorded 2 mentions for Delta 9 Cannabis and 1 mentions for Crescita Therapeutics. Crescita Therapeutics' average media sentiment score of 0.55 beat Delta 9 Cannabis' score of 0.00 indicating that Delta 9 Cannabis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crescita Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Delta 9 Cannabis
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Crescita Therapeutics beats Delta 9 Cannabis on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DN vs. The Competition

MetricDelta 9 CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$5.23MC$1.22BC$4.93BC$4.04B
Dividend YieldN/A2.99%44.82%7.14%
P/E Ratio-0.20485.69117.6224.71
Price / Sales0.078,078.062,468.451,848.70
Price / Cash4.479.9432.2373.20
Price / Book-0.676.825.023.59
Net Income-C$17.52MC$143.33MC$101.60MC$261.37M
7 Day PerformanceN/A5.85%5.41%1.09%
1 Month PerformanceN/A7.59%9.46%3.71%
1 Year PerformanceN/A42.39%9.72%17.68%

Delta 9 Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTX
Crescita Therapeutics
0 of 5 stars
N/AN/A-26.9%C$8.50MC$17.52M-4.3562
VPH
Valeo Pharma
0 of 5 stars
C$0.10
flat
N/A-74.1%C$9.87MC$54.29M-0.31100High Trading Volume
WLLW
Willow Biosciences
0 of 5 stars
C$0.09
flat
N/A-25.0%C$10.79MC$1.17M-0.8519Gap Up
TMD
Titan Medical
0 of 5 stars
C$0.06
flat
N/A-76.2%C$6.27MC$17.63M0.694Positive News
Gap Down
AEZS
Aeterna Zentaris
0 of 5 stars
C$11.60
+4.9%
N/A+189.3%C$14.04MC$4.50M-0.6211Gap Up
High Trading Volume

Related Companies and Tools

This page (TSE:DN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners